SGLT2 glucose reabsorption
Selected indexed studies
- SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits. (Cardiovasc Res, 2024) [PMID:38456601]
- Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2. (Diabetologia, 2018) [PMID:30132032]
- Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition. (Curr Vasc Pharmacol, 2017) [PMID:27748201]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits. (2024) pubmed
- Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2. (2018) pubmed
- Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition. (2017) pubmed
- Mouse Models with SGLT2 Mutations: Toward Understanding the Role of SGLT2 beyond Glucose Reabsorption. (2023) pubmed
- SGLT2 Inhibitors: Physiology and Pharmacology. (2021) pubmed
- Phytocannabinoids as Novel SGLT2 Modulators for Renal Glucose Reabsorption in Type 2 Diabetes Management. (2025) pubmed
- Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition. (2017) pubmed
- The tubular hypothesis of nephron filtration and diabetic kidney disease. (2020) pubmed
- Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors. (2012) pubmed
- SGLT2 inhibitors and acute kidney injury. (2026) pubmed